Mylan, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
MZT Holdings, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Myriad Genetics Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Misonix Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Medicis Pharmaceutical Corp.-Deals & Alliances Report
| Jan 2010 |
£375 |
Micromet, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Millipore Corp.-Deals & Alliances Report
| Jan 2010 |
£375 |
Masimo Corporation-Deals & Alliances Report
| Jan 2010 |
£375 |
Lexicon Pharmaceuticals, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Luminex Corporation-Deals & Alliances Report
| Jan 2010 |
£375 |
Eli Lilly & Co.-Deals & Alliances Report
| Jan 2010 |
£375 |
MDRNA, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Merck & Co. Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Sangamo Biosciences Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
SonoSite Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Seattle Genetics Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Strategic Diagnostics Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
SciClone Pharmaceuticals, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Let's Talk Recovery, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
3M Co.-Deals & Alliances Report
| Jan 2010 |
£375 |
Merge Healthcare Incorporated.-Deals & Alliances Report
| Jan 2010 |
£375 |
Monsanto Co.-Deals & Alliances Report
| Jan 2010 |
£375 |
MediciNova Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Merit Medical Systems Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Martek Biosciences Corp.-Deals & Alliances Report
| Jan 2010 |
£375 |
Maxygen, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Orchid Cellmark Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
OSI Pharmaceuticals Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Opko Health, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Onyx Pharmaceuticals Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Oncothyreon Inc-Deals & Alliances Report
| Jan 2010 |
£375 |
Osiris Therapeutics, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
OSI Systems, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Neurocrine Biosciences Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Nutrition 21 Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Nymox Pharmaceutical Corporation-Deals & Alliances Report
| Jan 2010 |
£375 |
OraSure Technologies Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
OmniComm Systems Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Omnicell Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Medtronic, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Medicines Co.-Deals & Alliances Report
| Jan 2010 |
£375 |
McKesson Corp.-Deals & Alliances Report
| Jan 2010 |
£375 |
MultiCell Technologies, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
MDS, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Mediware Information Systems Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Orthofix International NV-Deals & Alliances Report
| Jan 2010 |
£375 |
Omnicare Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
North American Scientific Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Nabi Biopharmaceuticals-Deals & Alliances Report
| Jan 2010 |
£375 |
Stem Cell Innovations, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Repros Therapeutics Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Osteotech, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Pressure BioSciences, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Poniard Pharmaceuticals, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Palomar Medical Technologies Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Penwest Pharmaceuticals Co.-Deals & Alliances Report
| Jan 2010 |
£375 |
Pacific Biometrics Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
PDL BioPharma, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Progenics Pharmaceuticals Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Procter & Gamble Co.-Deals & Alliances Report
| Jan 2010 |
£375 |
Phase Forward Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Pfizer Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Qiagen NV-Deals & Alliances Report
| Jan 2010 |
£375 |
Quadramed Corp.-Deals & Alliances Report
| Jan 2010 |
£375 |
Pro-Pharmaceuticals Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Perrigo Co.-Deals & Alliances Report
| Jan 2010 |
£375 |
Peregrine Pharmaceuticals Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Pharmaceutical Product Development Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Par Pharmaceutical Companies Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Parexel International Corp.-Deals & Alliances Report
| Jan 2010 |
£375 |
Quidel Corp.-Deals & Alliances Report
| Jan 2010 |
£375 |
Questcor Pharmaceuticals, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Palatin Technologies Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
pSivida Corp.-Deals & Alliances Report
| Jan 2010 |
£375 |
PhotoMedex, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
PerkinElmer Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Sigma-Aldrich Corporation-Deals & Alliances Report
| Jan 2010 |
£375 |
Shire Limited-Deals & Alliances Report
| Jan 2010 |
£375 |
Santarus Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Senesco Technologies Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Sunesis Pharmaceuticals Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Regeneron Pharmaceuticals Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Repligen Corporation-Deals & Alliances Report
| Jan 2010 |
£375 |
Rochester Medical Corp.-Deals & Alliances Report
| Jan 2010 |
£375 |
Rexahn Pharmaceuticals, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
ResMed Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Rigel Pharmaceuticals, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Smith & Nephew plc-Deals & Alliances Report
| Jan 2010 |
£375 |
Senomyx Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
SIGA Technologies Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Ardea Biosciences, Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
QLT Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Pall Corp.-Deals & Alliances Report
| Jan 2010 |
£375 |
Skinvisible Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Simulations Plus Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Senetek plc-Deals & Alliances Report
| Jan 2010 |
£375 |
Symyx Technologies Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
Salix Pharmaceuticals Ltd.-Deals & Alliances Report
| Jan 2010 |
£375 |
Somanetics Corp.-Deals & Alliances Report
| Jan 2010 |
£375 |
Panacos Pharmaceuticals Inc.-Deals & Alliances Report
| Jan 2010 |
£375 |
